Tradipitant is an oral neurokinin-1 (NK-1) receptor antagonist designed to inhibit substance P-mediated signaling, serving as an effective therapeutic option for managing nausea and vomiting associated… Read more
Tradipitant is an oral neurokinin-1 (NK-1) receptor antagonist designed to inhibit substance P-mediated signaling, serving as an effective therapeutic option for managing nausea and vomiting associated with chemotherapy, radiation therapy, and surgical procedures. By blocking the binding of substance P to NK-1 receptors within the central nervous system, this compound prevents emetic responses. This category provides a comprehensive selection of Tradipitant reference standards, including the active pharmaceutical ingredient, along with essential impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories rely on these high-quality materials to facilitate rigorous impurity profiling, method validation, and stability testing. These precise compounds support critical quality control workflows throughout the drug development process, ensuring compliance with regulatory standards for characterization and quantitation in complex analytical matrices.